Skip to main content

Table 1 IgAN relapses following COVID-19 vaccination

From: IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report

Author Age (Years) Sex Manufacture Dose (1st/2nd) Time between vaccine and onset (days) Presentation Pathology Treatment Response
Gul Rahim 52 F Pfizer 2nd  < 1 GH, AKI N/A None Remission of GH in less than 1 week
Negrea 38 F Pfizer 2nd  < 1 GH, SRP N/A None Remission of GH after 3 days
38 F Pfizer 2nd  < 1 GH N/A None Remission of GH after 3 days
Perrin 22 M Moderna 1st 2 GH N/A None Remission of GH
41 F Pfizer 1st 2 GH N/A None Remission of GH
27 F Pfizer 2nd 2 GH N/A None Remission of GH
Plasse N/A N/A Pfizer 2nd 5 to 6 GH, SRP, AKI N/A Corticosteroids Remission of GH, AKI after 1 month, SRP within 2 months
N/A N/A Pfizer 2nd 1 GH N/A None Remission of GH after 3 days
This Case 54 F Moderna 2nd 2 GH, SRP, AKI Active IgAN Corticosteroids Remission of GH after 2 days, AKI in 3 months
  1. Abbreviations: AKI Acute Kidney Injury, GH Gross Hematuria, SRP Subnephrotic Range Proteinuria